Park, Noh Jin <br/><br/>
Measurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagents.  [electronic resource] 

 -  PloS one  2013 
 - e71703 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0071703  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Aptamers, Nucleotide--genetics<br/>Binding Sites<br/>Binding, Competitive<br/>Biomarkers--blood<br/>Cetuximab<br/>Clinical Laboratory Techniques--methods<br/>Enzyme-Linked Immunosorbent Assay<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Panitumumab<br/>Polymerase Chain Reaction<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Receptor, ErbB-3--antagonists & inhibitors<br/>Receptor, ErbB-4<br/>Reproducibility of Results